Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Myintzu Min"'
Publikováno v:
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9:205521732211496
Background Cladribine is a useful therapeutic option in RRMS with moderate to high disease activity. Its oral formulation and tolerability make it a useful alternative to infusion therapies. Cladribine is known to deplete CD19+ B lymphocytes, but its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee7e83eeb3bc99b26d4bf84f7b4267b5
https://doi.org/10.1177/20552173221149688
https://doi.org/10.1177/20552173221149688
Autor:
Diana Ferraro, J. W. L. Brown, C. Ramo-Tello, Cameron Shaw, Mark Slee, Tomas Kalincik, Marc Girard, Xavier Ayrignac, Helmut Butzkueven, Jeannette Lechner-Scott, Julie Prevost, Roberto Bergamaschi, Alexandre Prat, D. Spitaleri, Pierre Grammond, Aysun Soysal, Myintzu Min, François Grand'Maison, Eugenio Pucci, Dana Horakova, Talal Al-Harbi, E. K. Havrdova, Maria Trojano, Franco Granella, G. De Luca, Giuseppe Iuliano, Alessandra Lugaresi, Pamela A. McCombe, A. Perez Sempere, C. Boz, Neil Shuey, Vincent Van Pesch, S. Ozakbas, Jose Luis Sanchez-Menoyo, Fraser Moore, Elena Tsantes, Vilija Jokubaitis, Tünde Csépány, R. Hupperts, M. Edite Rio, Patrizia Sola, B. Van Wijmeersch, Erica Curti, Guillermo Izquierdo, Pierre Duquette, Michael Hutchinson, Murat Terzi, R. Alroughani, Y. Sidhom
Publikováno v:
Multiple Sclerosis Journal. 23:976-1023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d78f35ba9788c69637bd8b1fa774af
https://doi.org/10.1177/1352458517733228
https://doi.org/10.1177/1352458517733228
Autor:
Maltby, Vicki E, Lea, Rodney A, Ribbons, Karen A, Sanders, Katherine A, Kennedy, Daniel, Myintzu Min, Scott, Rodney J, Lechner-Scott, Jeannette
Supplemental material for DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate by Vicki E Maltby, Rodney A Lea, Karen A Ribbons, Katherine A Sanders, Daniel Kennedy, Myintzu Min, Rodney J Scott and Je
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c006bcc4b353d2ae91e14cf3c1859fab
Autor:
Francois Grand'Maison, Raed Alroughani, Jeannette Lechner-Scott, Vincent Van Pesch, Michael Barnett, Maria Trojano, Franco Granella, Raymond Hupperts, Cavit Boz, Jose Luis Sanchez-Menoyo, Daniele Spitaleri, Eugenio Pucci, Patrizia Sola, Pierre Grammond, Pierre Duquette, Tomas Kalincik, Helmut Butzkueven, Marc Girard, Steve Vucic, Tim Spelman, Guillermo Izquierdo, Alessandra Lugaresi, Myintzu Min
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 24, no.12, p. 1569-1577 (2018)
Background: The current best practice suggests yearly magnetic resonance imaging (MRI) to monitor treatment response in multiple sclerosis (MS) patients. Objective: To evaluate the current practice of clinicians changing MS treatment based on subclin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f080394b049d52ec6eaa024df86be3
https://hdl.handle.net/2078.1/204684
https://hdl.handle.net/2078.1/204684
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 90:A34.1-A34
IntroductionAutoimmune encephalitides are a heterogenous and potentially devastating group of disorders. Antibodies to glycine receptor (GlyR) are rare and increasingly reported in patients with progressive encephalomyelitis with rigidity and myoclon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13637747f870b9e1bdc7c53ab26c3cb7
https://doi.org/10.1136/jnnp-2019-anzan.92
https://doi.org/10.1136/jnnp-2019-anzan.92
Publikováno v:
Journal of Neurology & Neurophysiology. 7
Neuromyelitis optica (NMO) is a rare but severely disabling disease, affecting predominantly the optic nerves and spinal cord. Aquaporin-4 (AQP4 IgG) antibodies have been described as characteristic and pathogenic for the disease. Some NMO cases are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa7314a59cecd2c1e7d13fbab4a86571
https://doi.org/10.4172/2155-9562.1000391
https://doi.org/10.4172/2155-9562.1000391
Autor:
Karen Ribbons, Jeannette Lechner-Scott, Myintzu Min, Vicki E. Maltby, Rodney J. Scott, Daniel W. Kennedy, Rodney A. Lea, Katherine A. Sanders
Publikováno v:
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 4:205521731878782
Background Dimethyl fumarate is an oral treatment for multiple sclerosis, whose mechanism of action is not fully understood. Objective To investigate the effects of dimethyl fumarate on DNA methylation in the CD4+ T cells of multiple sclerosis patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4d117e366bb80e26d1422d369412e24
https://doi.org/10.1177/2055217318787826
https://doi.org/10.1177/2055217318787826